- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
What We’re Reading: HHS to Expand Nursing Home Ownership Info; Unprotected Mental Health Data; FDA Rebuffs Cancer Drug
HHS wants to require nursing homes to disclose more ownership and management information; privacy advocates warn that mental health data can legally be sold from certain platforms not covered by the Health Insurance Portability and Accountability Act; the FDA won’t review Soligenix’s cancer drug proposal because of an insufficient application.
HHS Aims to Require Nursing Home Ownership Transparency
A new rule requiring nursing homes to offer more information on their ownership and management is being proposed by HHS, reported The Hill. Medicaid and Medicare enrolled nursing homes are required to release certain information on ownership and management, but the new rule would widen the realm of information offered so customers are fully aware of who owns, operates, and manages nursing homes, including if they are private equity investors or real estate investment trusts.
Sale of Mental Health Data Unprotected by Law
Data provided to telehealth and therapy apps are being sold by data brokers legally and without knowledge or consent, reported The Washington Post, citing the results of a study conducted by Duke University. The Health Insurance Portability and Accountability Act limits US health data shared by covered health entities like hospitals and doctor’s offices, but doesn’t protect information distribution through non-protected platforms, like some apps. A researcher was able to buy information from 11 companies, ranging from zip code level data to personally identifiable
FDA Won’t Review Soligenix’s Cancer Drug
On Tuesday, Soligenix said that its cancer drug proposal application won’t be reviewed by the FDA, which said it was incomplete, according to Reuters. The company wants the FDA’s assistance in helping the drug, HyBryte, move forward. The drug would be for the treatment of rare cancer T-cell lymphoma that starts in the white blood cells and attacks the skin.
AI in Health Care: Balancing Governance, Innovation, and Trust
September 2nd 2025In this conversation with Reuben Daniel, associate vice president of artificial intelligence at UPMC Health Plan, we dive into how UPMC Health Plan builds trust with providers and members, discuss challenges of scaling AI effectively, and hear about concrete examples of AI's positive impact.
Listen
Opportunities and Obstacles Associated With the Medicare Diabetes Prevention Program
October 3rd 2025This study describes the current opportunities and obstacles associated with Medicare Diabetes Prevention Program implementation from the novel perspective of program suppliers across the US.
Read More
Infertility Coverage Boosts ART Use and Pregnancy Success: Richard A. Brook, MS, MBA
August 26th 2025In this episode, Richard A. Brook, MS, MBA, discusses his study showing that infertility treatment coverage increases assisted reproductive technology (ART) use and improves pregnancy outcomes.
Listen
Managed Care Reflections: A Q&A With Ge Bai, PhD, CPA
October 2nd 2025To mark the 30th anniversary of The American Journal of Managed Care, each issue in 2025 includes a special feature: reflections from a thought leader on what has changed—and what has not—over the past 3 decades and what’s next for managed care. The October issue features a conversation with Ge Bai, PhD, CPA, professor of accounting at Johns Hopkins Carey Business School and professor of health policy and management at Johns Hopkins Bloomberg School of Public Health in Baltimore, Maryland.
Read More
